Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Neurogenetics ; 25(3): 193-200, 2024 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-38847891

RESUMO

Most of the heritability in frontotemporal dementia (FTD) is accounted for by autosomal dominant hexanucleotide expansion in the chromosome 9 open reading frame 72 (C9orf72), pathogenic/likely pathogenic variants in progranulin (GRN), and microtubule-associated protein tau (MAPT) genes. Until now, there has been no systematic analysis of these genes in the Serbian population. Herein, we assessed the frequency of the C9orf72 expansion, pathogenic/likely pathogenic variants in GRN and MAPT in a well-characterized group of 472 subjects (FTD, Alzheimer's disease - AD, mild cognitive impairment - MCI, and unspecified dementia - UnD), recruited in the Memory Center, Neurology Clinic, University Clinical Center of Serbia. The C9orf72 repeat expansion was detected in 6.98% of FTD cases (13.46% familial; 2.6% sporadic). In the UnD subgroup, C9orf72 repeat expansions were detected in 4.08% (8% familial) individuals. Pathogenic variants in the GRN were found in 2.85% of familial FTD cases. Interestingly, no MAPT pathogenic/likely pathogenic variants were detected, suggesting possible geographical specificity. Our findings highlight the importance of wider implementation of genetic testing in neurological and psychiatric practice managing patients with cognitive-behavioral and motor symptoms.


Assuntos
Proteína C9orf72 , Demência Frontotemporal , Progranulinas , Proteínas tau , Humanos , Proteínas tau/genética , Proteína C9orf72/genética , Progranulinas/genética , Feminino , Masculino , Idoso , Demência Frontotemporal/genética , Pessoa de Meia-Idade , Sérvia/epidemiologia , Expansão das Repetições de DNA/genética , Disfunção Cognitiva/genética , Disfunção Cognitiva/epidemiologia , Doença de Alzheimer/genética , Peptídeos e Proteínas de Sinalização Intercelular/genética , Idoso de 80 Anos ou mais
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA